Opioid receptor selectivity of heroin given intracerebroventricularly differs in six strains of inbred mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 2, 1999, Pages 438-445

  Rady, Jodie J ^a   Elmer, Gregory I ^b   Fujimoto, James M ^a  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; 7 BENZYLIDENENALTREXONE; BETA FUNALTREXAMINE; BICUCULLINE; DELTA OPIATE RECEPTOR; DIAMORPHINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; METHYSERGIDE; MORPHINE; MU OPIATE RECEPTOR; NALTRIBEN; NORBINALTORPHIMINE; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; INBRED STRAIN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; TAIL FLICK TEST;

ANIMALS; BICUCULLINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GABA ANTAGONISTS; GENOTYPE; HEROIN; INJECTIONS, INTRAVENTRICULAR; MALE; METHYSERGIDE; MICE; MICE, INBRED STRAINS; NARCOTIC ANTAGONISTS; NARCOTICS; NOCICEPTORS; PAIN MEASUREMENT; RECEPTORS, OPIOID; SEROTONIN ANTAGONISTS; SPECIES SPECIFICITY; SUBSTRATE SPECIFICITY;

EID: 0032988376     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. 5 (DAMGO) and morphine-induced antinociception in mice. J Pharmacol Exp Ther 256:890-896.
2. Belknap JK, Noordewier B and Lame M (1989) Genetic dissociation of multiple morphine effects among C57BL/6J, DBA/2J and C3H/HeJ inbred mouse strains. Physiol Behav 46:69-74.
3. Belknap JK and OToole L (1991) Studies of genetic differences in response to opioid drugs, in The Genetic Basis of Alcohol and Drug Actions (Crabbe JC and Harris RA eds) pp 225-252, Plenum Press, New York.
4. Brase DA, Loh HH and Way EL (1977) Comparison of the effects of morphine on locomotor activity, analgesia, and primary and protracted physical dependence in six mouse strains. J Pharmacol Exp Ther 201:368-374.
5. Brown GP, Yang K, King MA, Rossi GC, Leventhal L, Chang A and Pasternak GW (1997) 3-Methoxynaltrexone, a selective heroin/morphine-6β-glucuronide antagonist. FEBS Letters 412:35-38.
6. Castellano C and Oliverio A (1975) A genetic analysis of morphine-induced running and analgesia in the mouse. Psychopharmacology 41:197-200.
7. Crabbe JC, Belknap JK and Buck KJ (1994) Genetic animal models of alcohol and drug abuse. Science 264:1717-1723.
8. D'Amour FE and Smith DL (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74-79.
9. Dewey WL, Harris LS, Howes JF and Nuite J (1970) The effect of various neurohormonal modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J Pharmacol Exp Ther 175:434-442.
10. Elmer GI, Ladenheim B, Epstein C and Cadet JL (1995a) Transgenic superoxide dismutase mice differ in opioid-induced analgesia. Eur J Pharmacol 283:227-232.
11. Elmer GI, Ladenheim B, Sharpe LS, Goldberg SR, Epstein CJ and Cadet JL (1996) μ-Opiate receptor distribution in transgenic superoxide dismutase and inbred mice Soc Neurosci Abst 22:329.20.
12. Elmer G I, Pieper JO, Goldberg SR and George FR (1995b) Opioid operant self-administration, analgesia, stimulation, and respiratory depression in μ-deficient mice. Psychopharmacology 117:23-31,
13. Elmer GI, Pieper JO, Negus SS and Woods JH (1998) Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests. Pain 75:129-140.
14. Fox RR and Witham BA (1997) Handbook on Genetically Standardized Jax Mice, p 11, Jackson Laboratory, Bar Harbor, Maine.
15. Frischknecht HR, Siegfried B and Waser PG (1988) Opioids and behavior: Genetic aspects. Experientia 44:473-481.
16. Gwynn GJ and Domino EF (1984) Genotype-dependent behavioral sensitivity to mu vs. kappa opiate agonists. II. Antinociceptive tolerance and physical dependence. J Pharmacol Exp Ther 231:312-316.
17. Haley TJ and McCormick WG (1957) Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol 12:12-15.
18. Ho BY and Takemori AE (1989) Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist U50-488H. J Pharmacol Exp Ther 250:508-514.
19. 5]enkephalin, a delta opioid agonist, given intracerebroventricularly in the mouse, produces antinociception through mediation of spinal GABA receptors. Pharmacol Biochem Behav 49:675-682.
20. Horan P, Taylor J., Yamamura HI and Porreca F (1992) Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. J Pharmacol Exp Ther 260:1237-1243.
21. Hylden JLK and Wilcox GL (1980) Intrathecal morphine in mice: a new technique. Eur J Pharmacol 67:313-316.
22. Litchfield JT and Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99-113.
23. Mickley GA, Mulvihill MA and Postler MA (1990) Brain μ and δ opioid receptors mediate different locomotor and hyperactivity responses of the C57BL/6J mouse. Psychopharmacology 101:332-337.
24. Rady JJ, Aksu F and Fujimoto JM (1994a) The heroin metabolite, 6-monoacetylmorphine, activates delta opioid receptors to produce antinociception in Swiss Webster mice. J Pharmacol Exp Ther 266:1222-1231.
25. Rady JJ and Fujimoto JM (1995) Spinal GABA receptors mediate brain delta opioid analgesia in Swiss-Webster mice. Pharmacol Biochem Behav 51:655-659.
26. 2 opioid agonist analgesia in Swiss Webster mice involves spinal GABAA receptors. Pharmacol Biochem Behau 54:363-369.
27. Rady JJ, Roerig SC and Fujimoto JM (1991) Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception. J Pharmacol Exp Ther 256:448-457.
28. Rady JJ, Takemori AE, Portoghese PS and Fujimoto JM (1994b) Supraspinal delta receptor subtype activity of heroin and 6-monoacetylmorphine in Swiss Webster mice. Life Sci 55:603-609.
29. Roerig SC and Fujimoto JM (1989) Multiplicative interaction between intrathecally and intracere broventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice. J Pharmacol Exp Ther 249:762-768.
30. Semenova S, Kuzmin A and Zvartau E (1995) Strain differences in the analgesic and reinforcing action of morphine in mice. Pharmacol Biochem Behav 50:17-21.
31. Schuller AGP, King M, Zhang J, Czick M, Unterwald E, Pasternak, GW and Pintar JE (1997) Heroin and M6G analgesia are retained in mu opioid receptor deficient mice. Soc Neurosci Abst 23:235.6.
32. Steel RGD and Torrie JH (1960) Principles and Procedures of Statistics with Special Reference to the Biological Sciences, pp 99-111, McGraw-Hill Book Company, New York.
33. Suh HH, Fujimoto JM and Tseng LF (1989) Differential mechanisms mediate β-endorphin- and morphine-induced analgesia in mice. Eur J Pharmacol 168:61-70.
34. Taber RI (1974) Predicted value of analgesic assays in mice and rats. Adv Biochem Psychopharmacol 8:191-211.
35. Takemori AE, Ho BY, Naeseth JS and Portoghese PS (1988) Norbinaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J Pharmacol Exp Ther 246:255-258.
36. Takemori AE and Portoghese PS (1987) Evidence for the interaction of morphine with kappa and delta opioid receptors to induce analgesia in β-funaltrexamine-treated mice. J Pharmacol Exp Ther 243:91-94.
37. Wang FS, Rady JJ and Fujimoto JM (1994) Elimination of the antianalgesic action of dynorphin A by spinal transsection in barbital anesthetized mice. J Pharmacol Exp Ther 268:873-880.
38. Ward SJ, Portoghese PS and Takemori AE (1982) Pharmacological characterization in vivo of the novel opiate β-funaltrexamine. J Pharmacol Exp Ther 220:494-498.
39. Yaksh TL and Malmberg AB (1994) Central pharmacology of nociceptive transmission, in Textbook of Pain (Wall PD and Melzack R eds) pp165-200, Churchill Livingstone, Edinburgh.
40. Yukhananov RY, Klodt PM, Il'ina AD, Zaitsev SV and Maisky A (1994) I. Opiate withdrawal intensity correlates with the presence of DSLET high-affinity binding. Pharmacol Biochem Behav 49:1109-1112.